Akero Therapeutics, Inc.
2019 Q4 - 2025 Q3 (24 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q3 | 11/14/2025 | 2,544 | 0.0% | 53,572 | 9/30/2025 |
| 2025 Q2 | 8/14/2025 | 3,012 | 0.0% | 56,451 | 6/30/2025 |
| 2025 Q1 | 5/15/2025 | 1,888 | 0.0% | 46,641 | 3/31/2025 |
| 2024 Q4 | 3/18/2025 | 1,303 | 0.0% | 46,835 | 12/31/2024 |
| 2024 Q3 | 4/4/2025 | 1,354 | 0.0% | 47,208 | 9/30/2024 |
| 2024 Q2 | 4/8/2025 | 1,216 | 0.0% | 51,821 | 6/30/2024 |
| 2024 Q1 | 5/16/2024 | 1,369 | 0.0% | 54,185 | 3/31/2024 |
| 2023 Q4 | 2/13/2024 | 1,122 | 0.0% | 48,072 | 12/31/2023 |
| 2023 Q3 | 11/14/2023 | 2,554 | 0.0% | 50,500 | 9/30/2023 |
| 2023 Q2 | 8/21/2023 | 2,516 | 0.0% | 53,891 | 6/30/2023 |
| 2023 Q1 | 5/9/2023 | 1,518 | 0.0% | 39,674 | 3/31/2023 |
| 2022 Q4 | 2/14/2023 | 2,165 | 0.0% | 39,516 | 12/31/2022 |
| 2022 Q3 | 11/21/2022 | 1,239 | 0.0% | 36,386 | 9/30/2022 |
| 2022 Q2 | 8/15/2022 | 280 | 0.0% | 29,663 | 6/30/2022 |
| 2022 Q1 | 5/16/2022 | 353 | 0.0% | 24,908 | 3/31/2022 |
| 2021 Q4 | 2/15/2022 | 577 | 0.0% | 27,274 | 12/31/2021 |
| 2021 Q3 | 11/15/2021 | 597 | 0.0% | 26,721 | 9/30/2021 |
| 2021 Q2 | 8/16/2021 | 880 | 0.0% | 35,465 | 6/30/2021 |
| 2021 Q1 | 5/18/2021 | 594 | 0.0% | 20,489 | 3/31/2021 |
| 2020 Q4 | 2/16/2021 | 529 | 0.0% | 20,489 | 12/31/2020 |
| 2020 Q3 | 11/17/2020 | 631 | 0.0% | 20,489 | 9/30/2020 |
| 2020 Q2 | 8/17/2020 | 420 | 0.0% | 16,866 | 6/30/2020 |
| 2020 Q1 | 5/13/2020 | 270 | 0.0% | 12,723 | 3/31/2020 |
| 2019 Q4 | 2/14/2020 | 165 | 0.0% | 7,447 | 12/31/2019 |